Prev Arrow Stocks

Zoetis Inc. Class A ($ZTS) Stock Forecast: Up 5.2% Today

Morpher AI identified a bullish signal. The stock price may continue to rise based on the momentum of the good news.

What is Zoetis Inc. Class A?

Zoetis Inc. (NYSE: ZTS) is a prominent global animal health company known for its veterinary medicines and vaccines for livestock and companion animals.

Why is Zoetis Inc. Class A going up?

ZTS stock is up 5.2% on Nov 21, 2025 20:36

  • Zoetis Inc. (ZTS) saw a significant bullish movement today, despite recent declines in stock price over the past month and year.
  • Analysts are raising concerns about potential challenges in Zoetis' osteoarthritis pain franchise in a competitive market.
  • The surge in Zoetis' stock price today may be linked to market optimism or positive developments within the company.
  • Investors are keeping a close eye on Zoetis Inc.'s price over earnings ratio to assess if the stock is undervalued, potentially impacting today's bullish movement.

ZTS Price Chart

ZTS Technical Analysis

ZTS News

Zoetis Osteoarthritis Pain Franchise Needs A Reset: Analyst - Zoetis ( NYSE:ZTS )

As the animal health industry navigates a rapidly evolving landscape, companies are increasingly challenged to maintain their competitive edge through innovation and strategic adaptation.

https://www.benzinga.com/analyst-stock-ratings/initiation/25/11/49009564/zoetis-osteoarthritis-pain-franchise-needs-a-reset-analyst

0 News Article Image Zoetis Osteoarthritis Pain Franchise Needs A Reset: Analyst - Zoetis  ( NYSE:ZTS )

A Look Into Zoetis Inc's Price Over Earnings - Zoetis ( NYSE:ZTS )

In the current market session, Zoetis Inc. ( NYSE:ZTS ) price is at $117.53, after a 0.38% spike. However, over the past month, the stock fell by 20.42%, and in the past year, by 34.17%. Shareholders might be interested in knowing whether the stock is undervalued, even if the company is ...

https://www.benzinga.com/insights/news/25/11/48981651/a-look-into-zoetis-incs-price-over-earnings

1 News Article Image A Look Into Zoetis Inc's Price Over Earnings - Zoetis  ( NYSE:ZTS )

Zoetis Inc. Class A Price History

15.08.2025 - ZTS Stock was down 1.8%

  • Zoetis (ZTS) stock experienced a bearish movement today, closing at $149.79 with a -1.29% change compared to its last close.
  • A recent comparison between SDZNY and ZTS may have raised concerns among investors about the valuation and attractiveness of Zoetis stock.
  • The overall market gains might have shifted investor focus towards other sectors or stocks, leading to a sell-off in Zoetis shares.
  • The negative market sentiment towards Zoetis could also be influenced by broader economic factors or industry-specific news impacting the Medical Drugs sector.

18.05.2025 - ZTS Stock was down 5.2%

  • The bearish movement in Zoetis (ZTS) today may be attributed to the following factors:
  • Despite outperforming market returns recently, the stock could be facing profit-taking by investors following a period of gains.
  • Shifting market sentiment towards the animal health sector, possibly influenced by concerns over regulatory changes or competitive pressures.
  • External factors such as overall market volatility or economic indicators potentially impacting the stock's decline today.
  • Investor response to undisclosed news or events concerning Zoetis (ZTS), contributing to a downward trend in the stock price.

21.10.2025 - ZTS Stock was up 3.3%

  • Recent fluctuations in the stock price over the last month and year have been overshadowed by today's positive movement of 0.38% to $117.53, hinting at a possible change in investor sentiment.
  • The upward price trend could be linked to investors acknowledging Zoetis Inc.'s enduring value and growth opportunities within the animal health sector.
  • Shareholders are displaying optimism regarding the company's future, fueling heightened buying activity and lifting the stock price.
  • The surge in price relative to earnings signifies a reassessment of Zoetis Inc.'s worth by investors, positioning it as a potentially undervalued asset in the market.

21.10.2025 - ZTS Stock was up 5.2%

  • Zoetis Inc. (ZTS) saw a significant bullish movement today, despite recent declines in stock price over the past month and year.
  • Analysts are raising concerns about potential challenges in Zoetis' osteoarthritis pain franchise in a competitive market.
  • The surge in Zoetis' stock price today may be linked to market optimism or positive developments within the company.
  • Investors are keeping a close eye on Zoetis Inc.'s price over earnings ratio to assess if the stock is undervalued, potentially impacting today's bullish movement.

06.04.2025 - ZTS Stock was down 5.0%

  • Despite surpassing earnings and revenue expectations in Q1 and revising upwards its 2025 guidance, Zoetis (ZTS) faced a downward market trend.
  • The market's negative reaction to the raised tariffs outlined in the updated 2025 guidance has led to investor uncertainty.
  • The stock's decline over the last year, with a slight uptick in the most recent session, may also be influencing the prevailing bearish outlook.
  • Investors could be delving deeper than headline figures and core metrics to evaluate Zoetis's long-term growth prospects, resulting in cautious trading activities.

04.10.2025 - ZTS Stock was down 12.0%

  • Despite surpassing Q3 earnings estimates, Zoetis (ZTS) experienced a strong bearish movement in the market.
  • The market may have reacted negatively due to the slight revenue miss and uncertainties about future growth prospects.
  • Investors might have been expecting even stronger performance given the rising demand for companion animal products like Simparica Trio and Apoquel.
  • The bearish movement could also be influenced by profit-taking behavior following a period of sustained growth in the stock price.

04.10.2025 - ZTS Stock was down 13.3%

  • Despite beating third-quarter earnings estimates, Zoetis (ZTS) experienced a bearish market movement due to rising competitive pressures in the animal health industry.
  • The company's revenue growth expectations driven by products like Simparica Trio and Apoquel were overshadowed by concerns about increasing competition impacting future profitability.
  • Investors may have reacted negatively to the uncertainty surrounding Zoetis' ability to maintain its market position amidst growing competitive pressures, leading to the bearish movement in the stock price.

04.10.2025 - ZTS Stock was down 12.4%

  • The bearish movement in ZTS stock today could be attributed to profit-taking by investors after a period of strong growth.
  • Despite expectations of another earnings beat and anticipated revenue growth driven by popular products like Simparica Trio and Apoquel, the market may have had higher expectations than what was actually reported.
  • It's possible that uncertainties in the broader market or concerns about future growth prospects for the company could have also contributed to the bearish sentiment.
  • Investors might be waiting for more concrete data from Zoetis' Q3 earnings report to assess the company's performance and make informed decisions about their positions in the stock.

08.06.2025 - ZTS Stock was up 0.7%

  • The positive movement in ZTS today may stem from investors acknowledging the company's value in comparison to its peers like SGIOY.
  • Positive aspects of ZTS may have been emphasized in a recent comparison, sparking enhanced investor interest and pushing the stock price up.
  • The preference for ZTS over SGIOY could be attributed to its solid market standing and growth potential in the animal health sector.

13.01.2025 - ZTS Stock was down 9.2%

  • The bearish movement in ZTS stock today may be due to profit-taking by investors ahead of the company's upcoming Q4 earnings report. Despite positive performance metrics and anticipated earnings growth on Wall Street, market uncertainty could be causing this downward trend. Investors seem to be adopting a cautious approach, possibly concerned about meeting or surpassing high estimates.

13.01.2025 - ZTS Stock was down 7.1%

  • Despite exceeding Q4 earnings and revenue estimates, Zoetis (ZTS) experienced a decrease in its stock price due to its 2025 guidance falling short of expectations.
  • Investors appeared displeased with the projected revenue range of $9.225B-$9.375B for 2025, which was lower than market estimates.
  • The market's response indicates that although the company performed well in the recent quarter, concerns regarding its future growth projections and guidance resulted in the decline.
  • Emphasizing key metrics and Wall Street projections did not completely alleviate investor apprehensions about Zoetis' long-term prospects, contributing to the stock's downward trajectory.

04.03.2025 - ZTS Stock was down 5.0%

  • Zoetis (ZTS) stock experienced a bearish movement of -1.16% today.
  • The slight decline in ZTS stock could be attributed to profit-taking by investors after a recent bullish run.
  • Market sentiment may have been influenced by broader economic factors or sector-specific news impacting the animal health industry.
  • Investors might be closely monitoring upcoming developments or earnings reports from Zoetis to reassess their positions in the stock.
i
Disclaimer
Morpher is not liable for the content of the AI investment insights. Like most GPT-powered tools, these summaries may contain AI hallucinations and inaccurate information. Morpher is not presenting you with any investment advice. All investments involve risk, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. Such decisions should be based solely on an evaluation of their financial circumstances, investment objectives, risk tolerance, and liquidity needs. These summaries do not constitute investment advice.